Elucidating autoimmune nodopathies and the CIDP spectrum
Authors:
- 1 April 2021
- journal article
- editorial
- Published by Oxford University Press (OUP) in Brain
- Vol. 144 (4) , 1043-1045
Abstract
This scientific commentary refers to ‘Antibodies to the Caspr1/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathy’, by Pascual-Goñi et al. (doi:10.1093/brain/awab014).Keywords
This publication has 10 references indexed in Scilit:
- Antibodies to the Caspr1/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathyBrain, 2021
- Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 seraJournal of Neurology, 2020
- Boundaries of chronic inflammatory demyelinating polyradiculoneuropathyJournal of the Peripheral Nervous System, 2020
- Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDPNeurology Neuroimmunology & Neuroinflammation, 2020
- Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathyThe Lancet Neurology, 2019
- Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implicationsNature Reviews Neurology, 2017
- Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathyBrain, 2017
- Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathyBrain, 2016
- Antibodies to Heteromeric Glycolipid Complexes in Guillain-Barré SyndromePLOS ONE, 2013
- European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First RevisionEuropean Journal of Neurology, 2010